Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Conde

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2019
FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved EfficacyAlvaro Quintanal-Villalonga, Sonia Molina-Pinelo, Cristina Cirauqui, et al.
Journal of Fungi (Basel, Switzerland)|August 6, 2021
Epidemiology of Systemic Mycoses in the COVID-19 PandemicMaría Guadalupe Frías-De-León, Rodolfo Pinto-Almazán, Rigoberto Hernández-Castro, et al.
Future Oncology (London, England)|August 2, 2021
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challengesXabier Mielgo-Rubio, Margarita Martín, Jordi Remon, et al.
Cancer Cytopathology|July 29, 2020
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimensLukas Bubendorf, Esther Conde, Federico Cappuzzo, et al.
Journal of Clinical Medicine|March 25, 2022
Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to ImmunotherapyJavier Ramos-Paradas, David Gómez-Sánchez, Aranzazu Rosado, et al.
Cancers|November 25, 2020
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of BiomarkersXabier Mielgo-Rubio, Virginia Calvo, Javier Luna, et al.
JTO Clinical and Research Reports|February 25, 2025
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLCHelena Bote-de Cabo, Marco Siringo, Esther Conde, et al.
Biology|June 26, 2025
<i>Trichophyton rubrum</i> Phenotypic Virulence Factors in Mexican StrainsEsther Conde-Cuevas, Rigoberto Hernández-Castro, Claudia Erika Fuentes-Venado, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2023
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual SymposiumNuria Viñolas, Laura Mezquita, Jesús Corral, et al.
Plos One|September 3, 2010
The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lungEsther Conde, Bárbara Angulo, Pilar Redondo, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2019
FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved EfficacyAlvaro Quintanal-Villalonga, Sonia Molina-Pinelo, Cristina Cirauqui, et al.
Journal of Fungi (Basel, Switzerland)|August 6, 2021
Epidemiology of Systemic Mycoses in the COVID-19 PandemicMaría Guadalupe Frías-De-León, Rodolfo Pinto-Almazán, Rigoberto Hernández-Castro, et al.
Future Oncology (London, England)|August 2, 2021
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challengesXabier Mielgo-Rubio, Margarita Martín, Jordi Remon, et al.
Cancer Cytopathology|July 29, 2020
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimensLukas Bubendorf, Esther Conde, Federico Cappuzzo, et al.
Journal of Clinical Medicine|March 25, 2022
Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to ImmunotherapyJavier Ramos-Paradas, David Gómez-Sánchez, Aranzazu Rosado, et al.
Cancers|November 25, 2020
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of BiomarkersXabier Mielgo-Rubio, Virginia Calvo, Javier Luna, et al.
JTO Clinical and Research Reports|February 25, 2025
Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLCHelena Bote-de Cabo, Marco Siringo, Esther Conde, et al.
Biology|June 26, 2025
<i>Trichophyton rubrum</i> Phenotypic Virulence Factors in Mexican StrainsEsther Conde-Cuevas, Rigoberto Hernández-Castro, Claudia Erika Fuentes-Venado, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2023
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual SymposiumNuria Viñolas, Laura Mezquita, Jesús Corral, et al.
Plos One|September 3, 2010
The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lungEsther Conde, Bárbara Angulo, Pilar Redondo, et al.
Pageof 8